Company: MIRA
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022112
Chunk: 2

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 3
Chunk 2
---
 Document
  
    101.lab*
     
    Inline
    XBRL Taxonomy Label Linkbase Document
  
    101.pre*
     
    Inline
    XBRL Taxonomy Presentation Linkbase Document
  
    104*
     
    The
    cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL.

*Filed
                                            herewith.

**Furnished
                                            herewith.

19

SIGNATURES

Pursuant
to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    MIRA
    PHARMACEUTICALS, INC.

    Date:
    November 13, 2025
    By:
     /s/ Erez Aminov

    Erez
    Aminov

    Chief
    Executive Officer

    (Principal
    Executive Officer)

    Date:
    November 13, 2025
    By:
     /s/ Alan Weichselbaum

    Alan
    Weichselbaum

    Chief
    Financial Officer, Treasurer and Secretary

    (Principal
    Financial Officer)

20